CHANDAN HEALTHCARE LTD Stock Price Today (NSE: CHANDAN)
Fundamental Score
CHANDAN HEALTHCARE LTD Share Price — Live NSE/BSE Price, Fundamentals & Analysis
CHANDAN HEALTHCARE LTD share price today is ₹232.00, down 0.81% on NSE/BSE as of 23 June 2026. CHANDAN HEALTHCARE LTD (CHANDAN) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹826.72 (Cr). The 52-week high for CHANDAN share price is ₹358.00 and the 52-week low is ₹230.00. At a P/E ratio of 30.47x, CHANDAN is currently trading below its industry average P/E of 39.28x. The company has a Return on Equity (ROE) of 27.08% and a debt-to-equity ratio of 0.48.
CHANDAN HEALTHCARE LTD Share Price Chart — NSE/BSE Historical Performance
CHANDAN HEALTHCARE LTD share price chart: -8.04% return over the past month. 52-week high ₹358.00, 52-week low ₹230.00.
CHANDAN HEALTHCARE LTD — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹234.70 | ₹236.00 | ₹230.00 | ₹232.00 | 20.80K (Cr) | |
| ₹235.00 | ₹235.00 | ₹233.00 | ₹233.90 | 18.40K (Cr) | |
| ₹241.20 | ₹243.75 | ₹240.00 | ₹240.00 | 6.40K (Cr) | |
| ₹245.90 | ₹245.90 | ₹235.00 | ₹240.00 | 16.80K (Cr) | |
| ₹246.00 | ₹252.00 | ₹241.00 | ₹243.70 | 40.00K (Cr) | |
| ₹253.00 | ₹253.00 | ₹249.60 | ₹249.75 | 29.60K (Cr) | |
| ₹253.35 | ₹259.90 | ₹248.00 | ₹249.30 | 50.40K (Cr) | |
| ₹248.00 | ₹254.95 | ₹246.75 | ₹253.45 | 37.60K (Cr) | |
| ₹253.40 | ₹257.85 | ₹253.40 | ₹255.45 | 7.20K (Cr) | |
| ₹256.75 | ₹256.75 | ₹250.00 | ₹254.35 | 15.20K (Cr) |
CHANDAN HEALTHCARE LTD — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹234.70 | ₹236.00 | ₹230.00 | ₹232.00 | -1.15% | |
| ₹248.00 | ₹259.90 | ₹233.00 | ₹233.90 | -5.69% | |
| ₹244.60 | ₹257.85 | ₹240.10 | ₹255.45 | +4.44% | |
| ₹245.50 | ₹251.50 | ₹230.00 | ₹231.10 | -5.87% | |
| ₹274.95 | ₹307.00 | ₹264.00 | ₹275.85 | +0.33% | |
| ₹317.00 | ₹317.65 | ₹253.20 | ₹266.10 | -16.06% | |
| ₹338.00 | ₹338.00 | ₹272.00 | ₹319.00 | -5.62% | |
| ₹320.05 | ₹358.00 | ₹309.95 | ₹329.70 | +3.02% | |
| ₹256.00 | ₹265.00 | ₹252.00 | ₹256.80 | +0.31% |
AI Research Briefing
Powered by Gemini · 2026-04-15
Regional diagnostics play expanding aggressively, but liquidity and execution risks loom large.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Chandan Healthcare acquired Nishkam Imaging in New Delhi. Also, Chandan secured a tender for a 1.5 Tesla MRI system at Civil Hospital Rohtak.
CORE STORY (THE REAL GAME)
Chandan is a play on the expansion of diagnostic services in Tier 2/3 cities, leveraging government contracts and partnerships for growth. It's about capturing market share in underserved areas through affordable and accessible healthcare.
- Acquisition of Nishkam Imaging
- Secured MRI tender at Civil Hospital Rohtak
- Expansion into multiple states
- Significant order wins in PPP projects
- Successful integration of acquired entities
- Faster-than-expected margin improvement
- Micro-cap liquidity risk
- Geographic revenue concentration
- High expansion costs impacting EBITDA
FII decreased their holding by 2.75% and DII decreased their holding by 1.3% [cite: brief].
Increasing healthcare spending and government support for healthcare infrastructure are tailwinds.
Chandan secured a ₹26 Cr government PPP project.
Free Cash Flow 5Y: ₹None Cr [cite: brief].
Expect continued expansion and revenue growth, but monitor margin compression and execution risks. Focus on government contracts and partnership performance over the next 6 months.
Primary Thesis Risk
Failure to execute expansion plans and maintain profitability will crush the thesis.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
CHANDAN HEALTHCARE LTD Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
CHANDAN HEALTHCARE LTD Fundamental Analysis & Valuation Benchmarking
Educational evaluation of CHANDAN across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Strong Return on Equity (27.08%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (28.85%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Attractive Valuation (P/E: 30.47 vs Industry: 39.28)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (46.62%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (22.94%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Strong Interest Coverage (8.51x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Limited Institutional Interest (FII+DII: 6.13%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
CHANDAN HEALTHCARE LTD vs Healthcare Service Provider Peers
Peer Comparison - Healthcare Service Provider
Compare CHANDAN HEALTHCARE LTD with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
46.5/100 | ₹232.00₹232 | ₹826.72₹826.72 | 30.47Average 30.5 Average | 27.08%Excellent 27.08% Excellent | 28.85%Excellent 28.85% Excellent | 0.48Excellent 0.5 Excellent | — — | — — | 0.00% | |
Dr Lal PathLabs LtdDr Lal PathLabs... LALPATHLAB • 539524 | 64.3/100 | ₹1617.20₹1617 | ₹25557.40₹25557.40 | 47.83Average 47.8 Average | 24.30%Excellent 24.30% Excellent | 28.88%Excellent 28.88% Excellent | 0.07Excellent 0.1 Excellent | 16.69%Excellent 16.69% Excellent | 13.09%Good 13.09% Good | 0.79% |
Vijaya Diagnostic Centre LtdVijaya Diagnost... VIJAYA • 543350 | 53.7/100 | ₹1261.40₹1261 | ₹10272.45₹10272.45 | 67.39Average 67.4 Average | 19.00%Good 19.00% Good | 20.91%Excellent 20.91% Excellent | 0.42Excellent 0.4 Excellent | 18.97%Excellent 18.97% Excellent | 15.00%Excellent 15.00% Excellent | 0.20% |
Metropolis Healthcare LtdMetropolis Heal... METROPOLIS • 542650 | 48.9/100 | ₹536.15₹536 | ₹10124.28₹10124.28 | 63.98Average 64.0 Average | 11.53%Average 11.53% Average | 14.66%Average 14.66% Average | 0.14Excellent 0.1 Excellent | -0.56%Poor -0.56% Poor | 9.22%Good 9.22% Good | 0.20% |
Thyrocare Technologies LtdThyrocare Techn... THYROCARE • 539871 | 40.5/100 | ₹512.15₹512 | ₹7724.80₹7724.80 | 60.48Average 60.5 Average | 16.15%Good 16.15% Good | 24.78%Excellent 24.78% Excellent | 0.05Excellent 0.1 Excellent | -0.64%Poor -0.64% Poor | 9.62%Good 9.62% Good | 1.44% |
Krsnaa Diagnostics LtdKrsnaa Diagnost... KRSNAA • 543328 | 39.6/100 | ₹538.45₹538 | ₹2626.09₹2626.09 | 30.73Average 30.7 Average | 9.29%Poor 9.29% Poor | 12.52%Average 12.52% Average | 0.30Excellent 0.3 Excellent | 22.05%Excellent 22.05% Excellent | 21.41%Excellent 21.41% Excellent | 0.34% |
Suraksha Diagnostic LtdSuraksha Diagno... SURAKSHA • 544293 | 47.1/100 | ₹289.60₹290 | ₹1534.08₹1534.08 | 48.05Average 48.0 Average | 16.46%Good 16.46% Good | 17.84%Good 17.84% Good | 0.51Good 0.5 Good | 16.38%Excellent 16.38% Excellent | 9.86%Good 9.86% Good | 0.00% |
3B Blackbio Diagnostics Ltd3B Blackbio Dia... 3BBLACKBIO • 532067 | 66.1/100 | ₹1225.40₹1225 | ₹1080.56₹1080.56 | 22.01Average 22.0 Average | 19.40%Good 19.40% Good | 25.75%Excellent 25.75% Excellent | 0.00Excellent 0.0 Excellent | 44.03%Excellent 44.03% Excellent | 27.29%Excellent 27.29% Excellent | 0.32% |
One Global Service Provider IncOne Global Serv... ONEGLOBAL • 514330 | 69.5/100 | ₹424.15₹424 | ₹1070.08₹1070.08 | 24.39Average 24.4 Average | 42.31%Excellent 42.31% Excellent | 56.38%Excellent 56.38% Excellent | 0.00Excellent 0.0 Excellent | 128.82%Excellent 128.82% Excellent | — — | 0.00% |
Sastasundar Ventures LtdSastasundar Ven... SASTASUNDR • 533259 | 40.3/100 | ₹313.95₹314 | ₹1042.27₹1042.27 | — — | 4.63%Poor 4.63% Poor | -1.33%Poor -1.33% Poor | 0.01Excellent 0.0 Excellent | 23.31%Excellent 23.31% Excellent | 24.47%Excellent 24.47% Excellent | 0.00% |
Choksi Imaging LtdChoksi Imaging ... CHOKSI • 526546 | 45.3/100 | ₹126.35₹126 | ₹92.81₹92.81 | 55.91Average 55.9 Average | 6.63%Poor 6.63% Poor | 9.20%Poor 9.20% Poor | 1.18Average 1.2 Average | 32.13%Excellent 32.13% Excellent | 8.21%Good 8.21% Good | 0.00% |
Top Healthcare Service Provider Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Dr Lal PathLabs Ltd share price25557.40 Cr
- Vijaya Diagnostic Centre Ltd share price10272.45 Cr
- Metropolis Healthcare Ltd share price10124.28 Cr
- Thyrocare Technologies Ltd share price7724.80 Cr
- Krsnaa Diagnostics Ltd share price2626.09 Cr
CHANDAN HEALTHCARE LTD Quarterly Performance
Latest quarterly metrics for CHANDAN — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
22.94%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
46.62%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
CHANDAN HEALTHCARE LTD Technical Indicators
SMA 50, SMA 200, RSI and volume signals for CHANDAN — calculated from daily price history
Selling pressure is heavy — potential reversal zone.
Technical indicators are for educational purposes only. Not investment advice.
CHANDAN HEALTHCARE LTD Financial Statements
Annual income statement, balance sheet and cash flow for CHANDAN HEALTHCARE LTD (CHANDAN) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for CHANDAN HEALTHCARE LTD
About CHANDAN (CHANDAN HEALTHCARE LTD)
CHANDAN HEALTHCARE LTD (CHANDAN) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Healthcare Service Provider se...ctor with a current market capitalisation of ₹826.72 (Cr). CHANDAN HEALTHCARE LTD has delivered a Return on Equity (ROE) of 27.08% and a ROCE of 28.85%. The debt-to-equity ratio stands at 0.48, reflecting the company's capital structure. Investors tracking CHANDAN share price can monitor key metrics including P/E ratio, promoter holding of 49.47%, and quarterly earnings growth.
Company Details
CHANDAN Share Price: Frequently Asked Questions
What is the current share price of CHANDAN HEALTHCARE LTD?
CHANDAN HEALTHCARE LTD (CHANDAN) trades at ₹232.00 on NSE. Market cap ₹826.72 (Cr). Educational data only.
What is the P/E ratio of CHANDAN HEALTHCARE LTD?
CHANDAN HEALTHCARE LTD has a P/E of 30.47x vs industry average 39.28x.
What is the Bull Run score for CHANDAN HEALTHCARE LTD?
CHANDAN HEALTHCARE LTD has a Bull Run score of 46.5/100 based on 25+ financial parameters.
Does CHANDAN HEALTHCARE LTD pay dividends?
CHANDAN HEALTHCARE LTD has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of CHANDAN HEALTHCARE LTD?
CHANDAN HEALTHCARE LTD has ROE of 27.08%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of CHANDAN HEALTHCARE LTD?
CHANDAN HEALTHCARE LTD has debt-to-equity of 0.48.
Is CHANDAN HEALTHCARE LTD a good investment?
Bull Run gives CHANDAN HEALTHCARE LTD a score of 46.5/100. This is not investment advice — consult a SEBI-registered advisor.